Table 2: PTCL subtypes disease stage.
|
Stage |
Total |
|||
PTCL subtype [N = 60] |
stage |
n |
% |
n |
% |
Cutaneous |
|
|
|
9 |
15.0% |
Mycosis fungoides |
4 |
1 |
100% |
1 |
1.7% |
Transformed mycosis fungoides |
4 |
1 |
100% |
1 |
1.7% |
Sézary syndrome |
4 |
3 |
100% |
3 |
5.1% |
Primary cutaneous CD30 positive T-cell lymphoproliferative |
missing |
1 |
25% |
4 |
6.8% |
1 |
2 |
50% |
|||
3 |
1 |
25% |
|||
Extranodal |
8 |
13.3% |
|||
NKTCL nasal type |
1 |
1 |
20% |
5 |
8.5% |
2 |
3 |
60% |
|||
4 |
1 |
20% |
|||
Enteropathy-associated TCL |
2 |
1 |
33% |
3 |
5.1% |
4 |
2 |
67% |
|||
Nodal |
27 |
45.0% |
|||
PTCL-NOS |
3 |
4 |
33% |
12 |
20.3% |
4 |
8 |
67% |
|||
Anaplastic large cell lymphoma (ALK+/-) |
2 |
2 |
20% |
10 |
16.9% |
3 |
3 |
30% |
|||
4 |
5 |
50% |
|||
Angioimmunoblastic TCL |
3 |
2 |
40% |
5 |
8.5% |
4 |
3 |
60% |
|||
Leukemic |
|
13 |
21.7% |
||
Adult T-cellleukemia/lymphoma |
4 |
10 |
100% |
10 |
16.9% |
T-cell prolymphocytic leukemia |
4 |
1 |
100% |
1 |
1.7% |
T-cell large granular lymphocytic leukemia |
4 |
2 |
100% |
2 |
3.4% |
Lymphoblastic T-cell lymphoma |
2 |
1 |
50% |
2 |
3.4% |
4 |
1 |
50% |
|||
Subtype data missing |
1 |
1 |
100% |
1 |
1.7% |